Antibody · Oncology
AR-215
Tumour-targeting antibodyPlaceholder
An antibody programme exploring a tumour-restricted surface protein as a potential conjugate or bispecific anchor.
Development stage
- Discovery
- Lead optimisation
- Preclinical
- Clinical
Scientific rationale
- Antigen selected for tumour-versus-normal expression contrast across public atlases.